Systems, methods, and compositions provided herein relate to preparation of beads encapsulating biomolecules for performing sequential reactions on the biomolecules. Some embodiments include preparation of nucleic acid reactions within the bead, wherein the bead includes pores that allow diffusion of molecules into or out of the beads while retaining other molecules of interest.

Graphene oxide aerogel beads (GOABs) are formed that have a core/shell structure where a smooth shell covers a multi-layer core. The smooth shell and the layers of the multilayer core comprise graphene oxide or reduced graphene oxide. The GOABs can include a phase-change material encapsulated within the multi-layer core. The GOABs can be combined or decorated with Fe.sub.3O.sub.4 nanoparticles or MoS.sub.2 microflakes for various applications. The GOABs are formed from aqueous slurries of graphene oxide that is extruded as drops into an aqueous solution of a coagulant where GOABs are formed. The GOABs are washed and freeze dried, after which, the GOABs can be reduced as desired by chemical or thermal means. Impregnation can be carried out with the phase-change material.

Microencapsulation of bioactive and chemical cargo in a stable, cross-linked polymer matrix is presented that results in small particle sizes and is easily scaled-up for industrial applications. A formulation of a salt of an acid soluble multivalent ion, an acid neutralized with a volatile base and one or more monomers that cross-link in the presence of multivalent ions is atomized into droplets. Cross-linking is achieved upon atomization where the volatile base is vaporized resulting in a reduction of the pH of the formulation and the temporal release of multivalent ions from the salt that cross-link the monomers forming a capsule. The incorporation of additional polymers or hydrophobic compounds in the formulation allows control of hydration properties of the particles to control the release of the encapsulated compounds. The operational parameters can also be controlled to affect capsule properties such as particle-size and particle-size distribution.

The invention relates to a process for manufacturing a seamless breakable capsule, comprising co-extruding an external and hydrophilic liquid phase, and an internal and lipophilic liquid phase, in order to form a capsule constituted of a core comprising the internal and lipophilic phase, and a shell comprising the external and hydrophilic phase, immersing into an aqueous solution containing a curing agent, wherein the external liquid phase includes a gelling agent comprising gellan gum alone or in combination with another gelling agent, a filler, and a divalent metal sequestering agent, and to breakable capsules comprising a core and a shell, wherein the shell includes a gelling agent comprising gellan gum alone or in combination with another gelling agent, a filler, and a divalent metal sequestering agent.

A system and method are directed toward the synthesis of polymeric capsules using a phase inversion process by extrusion of polymeric droplets through a syringe-needle assembly or an iris-shutter mechanism. The polymeric solution may be prepared by dissolving PAN (polyacrylonitrile) polymer in DMF (Dimethyl Formamide) solvent at high temperature through continuous stirring. Following preparation of the capsules, further treatment was initiated using triethylamine in gelation bath to make the final product an efficient removal agent of water hardness.

Comestible products, for example beverage products, are disclosed containing encapsulated probiotic bacteria having resistance to subjection to at least thermal and acidic conditions. Beverage products include at least one aqueous liquid and capsules comprising a gelled mixture of alginate and denatured protein, and probiotic bacteria entrapped within the gelled mixture. The average particle size of the capsules is optionally less than 1000 microns (m) in diameter, such as less than 500 m in diameter. Methods are provided for making such encapsulated probiotics by providing a mixture comprising sodium alginate, denatured protein and active probiotic cells, and combining the mixture with a divalent cation to initiate cold gelation of the sodium alginate and denatured protein to form a second mixture. The second mixture is passed through an opening having a diameter of less than 1000 m to form capsules. The weight ratio of protein to alginate is from 1:1 to 9:1.

Embodiments of the present technology may include a system for forming an emulsion. The system may include a coiled tube. The coiled tube may have a first end and a second end. The second end may be located at a position higher than the position of the first end. The system may also include a plurality of beads disposed within the coiled tube. The system may further include a first inlet fluidly connected to the coiled tube. The first inlet may be configured to deliver a first fluid to the first end before the second end. In addition, the system may include a second inlet fluidly connected to the coiled tube. The second inlet may be configured to deliver a second fluid to the first end before the second end.

This invention refers to a paint composition with prolonged release biocides to repel, reduce, and control insects, characterized by: a) A cbp vehicle, preferably a water-based acrylic vinyl paint; b) At least one pyrethroid biocide or its mixture, selected from: b1) microencapsulated deltamethrin as an active ingredient: b2) microencapsulated cypermethrin as an active ingredient;

Where said pyrethroid biocides are activated or catalyzed through (PBO) piperonyl butoxide, and

Wherein said microcapsules of the active ingredients are obtained through a microencapsulation process by interfacial polymerization, and/or a microencapsulation by ionic gelation process, for a prolonged release with regards to the biocidal active ingredients' interval.

This invention relates to methods and systems for isolation of species in semi-permeable capsules and processing of encapsulated species through series of steps and/or reactions. To produce capsules, first aqueous two-phase system (ATPS) droplets are generated using microfluidics system. Then the hydrogel shell layer is hardened by inducing polymerization. As exemplified in this invention to achieve concentric ATPS droplet formation density-matched PEGDA and Dextran polymer solutions can be used. Once a capsule is formed, its composition can be changed by adding new reagents or replacing out old ones (e.g. by resuspending capsules in desired aqueous solution). The hydrogel shell of semi-permeable capsules can be dissolved at selected step during multi-step procedures to release the encapsulated species. This invention exemplifies isolation of individual cells within capsules and using the encapsulated cells for genotypic and phenotypic analysis. This invention also exemplifies use of capsules in multi-step procedures to perform complex biological reactions.

There is provided a method for producing hydrogel microparticles with spherical shape and having a narrow-disperse or mono-disperse size distribution. At least one temporary crosslinker such as those of formula (I), (Ila)-(Ilf) and at least one permanent crosslinker comprising two or more vinyl groups, such as: divinylbenzene (DVB), ethylene glycol dimethacrylate (EGDMA),diethyleneglycol dimethacrylate (DEGDMA), N,N-methylenebisacrylamide (MBA), oligo/poly ethyleneglycol dimethyacrylate, 1,4-butanediol dimethacrylate, and 1,6-hexanediol dimethacrylate are combined in an organic solvent having a polarity suitable for a precipitation polymerization to occur. The precipitation polymerization is allowed to take place without the addition of surfactant and/or stabilizer and/or the formed microparticles comprise less than 1% surfactant and/or stabilizer. These microparticles may be further functionalized to obtain amine and carboxylic acid units by functionalizing the monomers of the temporary crosslinkers. The functionalized microparticles are used for cryopreserving cells or as a vaccine delivery platform.

##STR00001##